Philip H. Elsinga
University Medical Center Groningen, University of Groningen
Papers
2
Total Citations
32
H-Index
2
About
Philip H. Elsinga is a pioneer in radiochemistry and molecular imaging, with a career dedicated to advancing positron emission tomography (PET) tracer development for clinical diagnostics. His primary research focuses on the automated synthesis of carbon-11 labeled amino acids and neurotransmitter precursors, enabling non-invasive visualization of metabolic processes in neuroendocrine tumors (NETs) and neurological disorders. Elsinga's major contributions include the development of a reliable remote-controlled synthesis of β-[¹¹C]-5-hydroxy-L-tryptophan (5-HTP) on a Zymark robotic system (2006, 21 citations), a breakthrough that improved the precision of NET staging by providing a robust method for producing this key PET tracer. Earlier, he pioneered the robotic synthesis of L-[1-¹¹C]tyrosine (1994, 11 citations), establishing foundational techniques for automated radiochemistry. His work has significantly impacted the field by making complex tracer production more reproducible and accessible, directly influencing clinical PET imaging protocols. Elsinga's achievements are recognized through his leadership in radiochemistry innovation, with his methods cited as benchmarks for automated synthesis in molecular imaging research.
Research Focus
Key Achievements
Top Papers
- 1
- 2Robotic synthesis of l-[1-11C]tyrosine11 citations · 1994